U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H14O7
Molecular Weight 306.2675
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EPIGALLOCATECHIN

SMILES

O[C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C3=CC(O)=C(O)C(O)=C3

InChI

InChIKey=XMOCLSLCDHWDHP-IUODEOHRSA-N
InChI=1S/C15H14O7/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6/h1-4,12,15-21H,5H2/t12-,15-/m1/s1

HIDE SMILES / InChI

Molecular Formula C15H14O7
Molecular Weight 306.2675
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

(-)-Epigallocatechin is a polyphenol, which occurs naturally in various plants, including green tea leaves. The compound was shown to have anti-cancer activity in vitro, with breast cancer, lung cancer, and colon cancer cells. The commercial preparation of Polyphenon E contains about 3% (-)-epigallocatechin as an impurity.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Determination of tea components with antioxidant activity.
2003-07-16
Complex effects of different green tea catechins on human platelets.
2003-07-10
Hop (Humulus lupulus L.) proanthocyanidins characterized by mass spectrometry, acid catalysis, and gel permeation chromatography.
2003-07-02
Inhibition of metalloproteinase-9 activity and gene expression by polyphenolic compounds isolated from the bark of Tristaniopsis calobuxus (Myrtaceae).
2003-07
Identification of potential aryl hydrocarbon receptor antagonists in green tea.
2003-07
Chain-breaking antioxidant activity of natural polyphenols as determined during the chain oxidation of methyl linoleate in Triton X-100 micelles.
2003-06-15
Radical chemistry of epigallocatechin gallate and its relevance to protein damage.
2003-06-01
Antitumor principle constituents of Myrica rubra Var. acuminata.
2003-05-07
Microemulsion electrokinetic chromatography for the analysis of green tea catechins: effect of the cosurfactant on the separation selectivity.
2003-05
Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate.
2003-05
The specificities of protein kinase inhibitors: an update.
2003-04-01
Inhibition of adenovirus infection and adenain by green tea catechins.
2003-04
DNA degradation by water extract of green tea in the presence of copper ions: implications for anticancer properties.
2003-04
Glucuronides of tea catechins: enzymology of biosynthesis and biological activities.
2003-04
MALDI-TOF mass spectrometry and PSD fragmentation as means for the analysis of condensed tannins in plant leaves and needles.
2003-04
Factors affecting the levels of tea polyphenols and caffeine in tea leaves.
2003-03-26
Determination of tea polyphenols and caffeine in tea flowers (Camellia sinensis) and their hydroxyl radical scavenging and nitric oxide suppressing effects.
2003-02-12
Antioxidative compounds from Crotalaria sessiliflora.
2003-02
Green tea catechins evoke a phasic contraction in rat aorta via H2O2-mediated multiple-signalling pathways.
2003-01-25
Epimerization of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate: relationship between epimerization and chemical structure.
2003-01-15
Polymeric proanthocyanidins from the bark of Hamamelis virginiana.
2003-01
Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier.
2003-01
Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects.
2003
Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins.
2003
Analysis of oxidized epigallocatechin gallate by liquid chromatography/mass spectrometry.
2003
Topoisomerase I and II enzyme inhibitory aqueous extract of Ardisia compressa and ardisin protect against benomyl oxidation of hepatocytes.
2002-12-18
(-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts.
2002-12
Antioxidant effects of green tea polyphenols on free radical initiated peroxidation of rat liver microsomes.
2002-12
Direct scavenging of nitric oxide and superoxide by green tea.
2002-12
Tea enhances insulin activity.
2002-11-20
Green tea polyphenols inhibit metalloproteinase activities in the skin, muscle, and blood of rainbow trout.
2002-11-20
Effects of external factors on the interaction of tea catechins with lipid bilayers.
2002-11
Accumulation of epigallocatechin quinone dimers during tea fermentation and formation of theasinensins.
2002-11
Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats.
2002-11
Regulation of IGFBP-5 expression during tumourigenesis and differentiation of oral keratinocytes.
2002-11
Effects of catechins on vascular tone in rat thoracic aorta with endothelium.
2002-10-11
Opportunities for nutritional amelioration of radiation-induced cellular damage.
2002-10
Varietal differences among the polyphenol profiles of seven table grape cultivars studied by LC-DAD-MS-MS.
2002-09-25
Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate.
2002-09
Activity-guided fractionation of green tea extract with antiproliferative activity against human stomach cancer cells.
2002-09
Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China.
2002-09
Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action.
2002-08-23
Effect of tea catechins on cellular lipid peroxidation and cytotoxicity in HepG2 cells.
2002-07
Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats.
2002-07
Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins.
2002-06
Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2).
2002-05-20
Effects of epigallocatechin 3-O-gallate on cellular antioxidative system in HepG2 cells.
2002-04
Inhibition of BMP-induced ectopic bone formation by an antiangiogenic agent (epigallocatechin 3-gallate).
2002
[Study on the analytical methods of catechins in tea and green tea polyphenol samples by high performance liquid chromatography].
2001-09
Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production.
2001
Patents

Sample Use Guides

In a clinical trial, patients were given 1, 2, 3 or 4 capsules (1 capsule contains 37 mg (-)-epigallocatechin).
Route of Administration: Oral
In a cell growth assay, human tumor cell lines MCF-7, SF-268, HCT-116 and NCI-H460 were treated with 100, 50, 25, 12.5, and 6.25 uM of (-)-epigallocatechin for 48 h. At concentration of 50 uM, the drug gave 50%, 10%, 60% and 40% inhibition of growth of breast, CNS, colon, and lung cancer cells, respectively.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:32:52 GMT 2025
Edited
by admin
on Mon Mar 31 18:32:52 GMT 2025
Record UNII
7Z197MG6QL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SUNPHENON EGC
Preferred Name English
EPIGALLOCATECHIN
Common Name English
EGC
Common Name English
(-)-EPIGALLOCATECHOL
Common Name English
EPIGALLOCATECHOL
Common Name English
2H-1-BENZOPYRAN-3,5,7-TRIOL, 3,4-DIHYDRO-2-(3,4,5-TRIHYDROXYPHENYL)-, (2R,3R)-
Systematic Name English
GALLOEPICATECHIN
Common Name English
(-)-EPI-GALLOCATECHIN
Common Name English
(-)-EPIGALLOCATECHIN
Common Name English
NSC-674039
Code English
EPI-GALLOCATECHIN
Common Name English
L-EPIGALLOCATECHIN
Common Name English
ANTISCURVY FACTOR C2
Common Name English
3,3',4',5,5',7-FLAVANHEXOL
Systematic Name English
(-)-EPIGALLOCATECHIN(EGC) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT) [DSC]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C63651
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
Code System Code Type Description
CHEBI
42255
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
SMS_ID
100000137992
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
DRUG BANK
DB03823
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
CAS
970-74-1
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
NSC
674039
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
EPA CompTox
DTXSID40891550
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
PUBCHEM
72277
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
FDA UNII
7Z197MG6QL
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
EVMPD
SUB77259
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
NCI_THESAURUS
C68453
Created by admin on Mon Mar 31 18:32:52 GMT 2025 , Edited by admin on Mon Mar 31 18:32:52 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT